These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17477789)

  • 1. Predicted B-cell epitopes of HER-2 oncoprotein by a bioinformatics method: a clue for breast cancer vaccine development.
    Wiwanitkit V
    Asian Pac J Cancer Prev; 2007; 8(1):137-8. PubMed ID: 17477789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico design of discontinuous peptides representative of B and T-cell epitopes from HER2-ECD as potential novel cancer peptide vaccines.
    Manijeh M; Mehrnaz K; Violaine M; Hassan M; Abbas J; Mohammad R
    Asian Pac J Cancer Prev; 2013; 14(10):5973-81. PubMed ID: 24289611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses.
    Dakappagari NK; Pyles J; Parihar R; Carson WE; Young DC; Kaumaya PT
    J Immunol; 2003 Apr; 170(8):4242-53. PubMed ID: 12682258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding a T-cell epitope for a melanoma vaccine by an immunomics technique.
    Wiwanitkit V
    Asian Pac J Cancer Prev; 2006; 7(4):659-60. PubMed ID: 17250448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities.
    Dakappagari NK; Lute KD; Rawale S; Steele JT; Allen SD; Phillips G; Reilly RT; Kaumaya PT
    J Biol Chem; 2005 Jan; 280(1):54-63. PubMed ID: 15507452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear and conformational B cell epitope prediction of the HER 2 ECD-subdomain III by in silico methods.
    Mahdavi M; Mohabatkar H; Keyhanfar M; Dehkordi AJ; Rabbani M
    Asian Pac J Cancer Prev; 2012; 13(7):3053-9. PubMed ID: 22994709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and Characterization of New Anti-HER2 Monoclonal Antibodies.
    Mahdavi M; Keyhanfar M; Jafarian A; Mohabatkar H; Rabbani M
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):213-21. PubMed ID: 26090600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancer.
    Baloria U; Akhoon BA; Gupta SK; Sharma S; Verma V
    Amino Acids; 2012 Apr; 42(4):1349-60. PubMed ID: 21229277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine.
    Disis ML; Grabstein KH; Sleath PR; Cheever MA
    Clin Cancer Res; 1999 Jun; 5(6):1289-97. PubMed ID: 10389911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicted epitopes of malarial merozoite surface protein 1 by bioinformatics method: a clue for further vaccine development.
    Wiwanitkit V
    J Microbiol Immunol Infect; 2009 Feb; 42(1):19-21. PubMed ID: 19424554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu (657-665) represents an immunogenic epitope of HER-2/neu oncoprotein with potent antitumor properties.
    Gritzapis AD; Fridman A; Perez SA; La Monica N; Papamichail M; Aurisicchio L; Baxevanis CN
    Vaccine; 2009 Dec; 28(1):162-70. PubMed ID: 19799847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
    Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
    J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary breast cancer vaccine study shows promise.
    Bankhead C
    J Natl Cancer Inst; 2007 Jun; 99(11):836. PubMed ID: 17551143
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).
    Gabrielli F; Salvi R; Garulli C; Kalogris C; Arima S; Tardella L; Monaci P; Pupa SM; Tagliabue E; Montani M; Quaglino E; Stramucci L; Curcio C; Marchini C; Amici A
    PLoS One; 2013; 8(3):e58358. PubMed ID: 23555577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer.
    Shariat S; Badiee A; Jalali SA; Mansourian M; Yazdani M; Mortazavi SA; Jaafari MR
    Cancer Lett; 2014 Dec; 355(1):54-60. PubMed ID: 25224570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based peptide mimicry of tumor-associated antigens.
    Ohtaki A; Kieber-Emmons T; Murali R
    Monoclon Antib Immunodiagn Immunother; 2013 Feb; 32(1):1-5. PubMed ID: 23600498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted epitopes of Lig A of Leptospira interrogans by bioinformatics method: a clue for further vaccine development.
    Wiwanitkit V
    Vaccine; 2007 Apr; 25(15):2768-70. PubMed ID: 17239493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.
    Dakappagari NK; Douglas DB; Triozzi PL; Stevens VC; Kaumaya PT
    Cancer Res; 2000 Jul; 60(14):3782-9. PubMed ID: 10919651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer vaccines: current research and future prospects.
    Cameron DA
    Expert Rev Vaccines; 2002 Jun; 1(1):29-34. PubMed ID: 12908510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.
    Wagner S; Jasinska J; Breiteneder H; Kundi M; Pehamberger H; Scheiner O; Zielinski CC; Wiedermann U
    Breast Cancer Res Treat; 2007 Nov; 106(1):29-38. PubMed ID: 17203384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.